Wells Fargo’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.73M | Sell |
75,788
-8,486
| -10% | -$306K | ﹤0.01% | 2675 |
|
|
2025
Q1 | $2.62M | Buy |
84,274
+14,154
| +20% | +$441K | ﹤0.01% | 2615 |
|
|
2024
Q4 | $1.79M | Buy |
70,120
+15,790
| +29% | +$403K | ﹤0.01% | 2877 |
|
|
2024
Q3 | $1.54M | Buy |
54,330
+6,174
| +13% | +$175K | ﹤0.01% | 2937 |
|
|
2024
Q2 | $1.27M | Sell |
48,156
-2,189
| -4% | -$57.7K | ﹤0.01% | 3027 |
|
|
2024
Q1 | $1.53M | Buy |
50,345
+35,453
| +238% | +$1.08M | ﹤0.01% | 2873 |
|
|
2023
Q4 | $418K | Buy |
14,892
+311
| +2% | +$8.74K | ﹤0.01% | 3623 |
|
|
2023
Q3 | $396K | Sell |
14,581
-28,820
| -66% | -$782K | ﹤0.01% | 3645 |
|
|
2023
Q2 | $1.33M | Buy |
43,401
+8,202
| +23% | +$252K | ﹤0.01% | 3059 |
|
|
2023
Q1 | $1.27M | Buy |
35,199
+12,571
| +56% | +$453K | ﹤0.01% | 3008 |
|
|
2022
Q4 | $894K | Sell |
22,628
-16,170
| -42% | -$639K | ﹤0.01% | 3116 |
|
|
2022
Q3 | $1.56M | Buy |
38,798
+3,642
| +10% | +$146K | ﹤0.01% | 2751 |
|
|
2022
Q2 | $1.48M | Buy |
35,156
+7,547
| +27% | +$317K | ﹤0.01% | 2854 |
|
|
2022
Q1 | $1.08M | Buy |
27,609
+3,543
| +15% | +$138K | ﹤0.01% | 3599 |
|
|
2021
Q4 | $959K | Sell |
24,066
-32,848
| -58% | -$1.31M | ﹤0.01% | 3888 |
|
|
2021
Q3 | $2.06M | Sell |
56,914
-49,210
| -46% | -$1.78M | ﹤0.01% | 3470 |
|
|
2021
Q2 | $4.35M | Buy |
106,124
+70,277
| +196% | +$2.88M | ﹤0.01% | 2866 |
|
|
2021
Q1 | $1.56M | Sell |
35,847
-350,796
| -91% | -$15.3M | ﹤0.01% | 3681 |
|
|
2020
Q4 | $19.4M | Buy |
386,643
+357,244
| +1,215% | +$17.9M | ﹤0.01% | 1576 |
|
|
2020
Q3 | $1.24M | Sell |
29,399
-336,931
| -92% | -$14.2M | ﹤0.01% | 3615 |
|
|
2020
Q2 | $17.8M | Buy |
+366,330
| New | +$17.8M | 0.01% | 1432 |
|